Acrivon Therapeutics, Inc. Common Stock

ACRV · NASDAQ
Analyze with AI
9/30/2025
6/30/2025
3/31/2025
12/31/2024
Assets
Cash & Equivalents$35,405$41,895$39,154$39,818
Short-Term Investments$93,849$95,528$110,481$139,662
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$1,107$989$1,692$2,149
Total Curr. Assets$130,361$138,412$151,327$181,629
Property Plant & Equip (Net)$7,981$8,124$7,982$8,025
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$5,108$10,199$15,195$5,089
Tax Assets$0$0$0$0
Other NC Assets$1,849$1,848$1,845$1,845
Total NC Assets$14,938$20,171$25,022$14,959
Other Assets$0$0$0$0
Total Assets$145,299$158,583$176,349$196,588
Liabilities
Payables$996$1,163$3,691$758
Short-Term Debt$1,184$1,148$1,105$1,057
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$12,711$11,120$8,754$15,399
Total Curr. Liab.$14,891$13,431$13,550$17,214
LT Debt$1,805$2,115$2,409$2,588
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$1,805$2,115$2,409$2,588
Other Liabilities$0$0$0$0
Cap. Leases$0$2,115$3,514$2,588
Total Liabilities$16,696$15,546$15,959$19,802
Equity
Pref Stock$0$0$0$0
Common Stock$31$31$31$31
Retained Earnings-$255,896-$237,662-$216,656-$196,976
AOCI$112$106$283$447
Other Equity$384,356$380,562$376,732$373,284
Total Equity$128,603$143,037$160,390$176,786
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$145,299$158,583$176,349$196,588
Net Debt-$32,416-$38,632-$35,640-$36,173
Acrivon Therapeutics, Inc. Common Stock (ACRV) Financial Statements & Key Stats | AlphaPilot